Resources to help you order Novoeight® (Antihemophilic Factor [Recombinant])

Contact a distributor

The following is a list of vendors who distribute Novoeight®. Simply contact a vendor directly to place your order.

ACCREDO HEALTH GROUP, INC.
(HEMOPHILIA HEALTH SERVICES)

1680 Century Center Parkway, Suite 8
Memphis, TN 38134
1-866-721-6118
Wholesalemem@accredo.com

ASD HEALTHCARE
3101 Gaylord Parkway
Frisco, TX 75034
1-800-746-6273
asdhealthcare.com

CUBIXX—ASD’s RFID DISPENSING CABINET
1-877-428-2499 (1-877-4CUBIXX)
consignment@asdhealthcare.com

BDI PHARMA, INC.
CONSIGNADVANTAGE—
BDI’s FACTOR CONSIGNMENT PROGRAM
120 Research Drive
Columbia, SC 29203
1-800-948-9834
consignadvantage.com

BIOCARE
2826 South Potter Drive
Tempe, AZ 85282
1-800-304-3064
biocare-us.org

CARDINAL HEALTH, SPECIALTY
PHARMACEUTICAL DISTRIBUTION
305 Tech Park Drive, Suite 113
La Vergne, TN 37086
1-866-677-4844 or 1-615-287-5341
cardinalhealth.com/us/en/spd

FFF ENTERPRISES
41093 County Center Drive
Temecula, CA 92591
1-800-843-7477
1-951-296-2500 (x1139)
fffenterprises.com

FFF’S RFID DISPENSING CABINET–
VERIFIED INVENTORY PROGRAM (VIP)
1-951-296-2500 (x1142)

MCKESSON PLASMA AND BIOLOGICS, LLC
401 Mason Road
La Vergne, TN 37086
1-877-625-2566
mckesson.com
plasma@mckesson.com

NATIONAL HOSPITAL SPECIALTIES
465 Rt. 17
Ramsey, NJ 07446
1-800-344-6087
nhsusa.com
info@nhsusa.com

PRODIGY HEALTH SUPPLIER CORP.
9417 Brodie Lane
Austin, TX 78748
1-877-693-4376
phscorporation.com


Selected Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Novoeight® is not indicated for the treatment of von Willebrand disease.
 

Important Safety Information

Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins.

Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment.

Development of activity-neutralizing antibodies (inhibitors) may occur.  If expected plasma factor VIII activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform an assay that measures factor VIII inhibitor concentration.

The most frequently reported adverse reactions (≥0.5%) were injection site reactions, increased hepatic enzymes, and pyrexia.


Please click here for Novoeight® Prescribing Information.